The screening for cytomegalovirus antibody in semen donors and recipients within a donor insemination programme

J R Prior1, D R Morroll, A G Birks

  • 1Manchester Fertility Services, Manchester BUPA Hospital, UK.

Insights

Cytomegalovirus (CMV) immunoglobulin G antibodies were detected in 16% of Caucasian and 80% of non-Caucasian semen donors. Among recipients, 38% of Caucasian and 94% of non-Caucasian women tested positive for CMV.

Area of Science:

  • Immunology
  • Virology
  • Reproductive Health

Background:

  • Cytomegalovirus (CMV) is a common virus that can be transmitted through bodily fluids.
  • Screening for CMV in semen donors and recipients is important for preventing transmission in assisted reproductive technologies.

Purpose of the Study:

  • To determine the prevalence of immunoglobulin G (IgG) antibodies to CMV in semen donors and women undergoing donor insemination.
  • To investigate potential associations between CMV seropositivity and demographic factors like ethnicity and age.

Main Methods:

  • Semen donors (n=67) and women receiving donor insemination (n=131) were tested for CMV IgG antibodies.
  • Participants were categorized by ethnicity (Caucasian and non-Caucasian) and age.

Main Results:

  • CMV IgG antibodies were found in 16% of Caucasian donors and 80% of non-Caucasian donors.
  • Among recipients, 38% of Caucasian women and 94% of non-Caucasian women tested positive for CMV IgG.
  • A significant association was observed between CMV seropositivity and age in Caucasian recipients.

Conclusions:

  • Non-Caucasian individuals exhibited a higher prevalence of CMV IgG antibodies in both donor and recipient groups.
  • Age is a significant factor associated with CMV seropositivity in Caucasian women receiving donor insemination.
  • These findings highlight the importance of CMV screening in donor insemination programs, considering ethnic and age-related differences.